🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of Different Grafting Technique of Thin Gingival Phenotype With Delayed Dental Implants

RecruitingNAAges 20 Years - 50 YearsAllFuture University in Egypt
NCT07892820 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Implant dentistry has become a fundamental aspect of modern dental practice, with its success now determined by more than just Osseo integration. Various factors play a critical role in the long-term success of dental implants, one of the most important being the stability of the peri-implant soft tissues, which are essential for maintaining both function and aesthetics. This study aims to compare the outcomes of sub epithelial connective tissue grafts and de-epithelialized connective tissue grafts in conjunction with delayed implant placement.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Thin gingival phenotype \< 1.5mm.\[6\] * Medical free. * Single edentulous area. * Age range is between 20 to 50 years. * Gingival recession. * Free from any periodontal disease. * Positive patient's acceptance for participating in the study. * Patients able to sign informed consent. * Non-smokers. * Moderate palatal vault. * Thickness of palatal graft not \<2mm. * Width of bone not \<8mm. Exclusion Criteria: * Psychologically disturbed patients. * Patients with a history of allergy to any medication used in the study were excluded. * Osteoporosis. * Parafunctional habit. * Patients taking anticoa * Gulant therapy.
💊

What it tests

  • De-epithelized connective tissue graft
  • Sub-epithelized connective tissue graft
📍

Where

1 site
Future University in Egypt
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy